Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inhibikase Therapeutics (IKT)
NASDAQ:IKT
RESEARCH TOOLSreports
Inhibikase Therapeutics (IKT) Ownership - Who Owns Inhibikase Therapeutics?
91 Followers
Inhibikase Therapeutics (IKT) Ownership Overview
83.12%
Insiders
1.84% Mutual Funds
0.56% Other Institutional Investors
14.48% Public Companies and
Individual Investors
The ownership structure of Inhibikase Therapeutics (IKT) stock is a mix of institutional, retail and individual investors. Approximately 2.40% of the company’s stock is owned by Institutional Investors, 83.12% is owned by Insiders and 14.48% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 83,885 | Institution | 1.30% | 143,443 | |
| 27,688 | Institution | 0.43% | 47,346 | |
| 16,724 | Institution | 0.26% | 28,598 | |
| 5,500 | Institution | 0.08% | 9,405 | |
| 1,913 | Institution | 0.03% | 3,271 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 83,885 | Institution | 1.30% | 143,443 | |
| 27,688 | Institution | 0.43% | 47,346 | |
| 5,500 | Institution | 0.08% | 9,405 | |
| 1,913 | Institution | 0.03% | 3,271 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 16,724 | Institution | 0.26% | 36,124 |
FAQ
Who Owns Inhibikase Therapeutics (IKT)?
According to the latest TipRanks data, approximately 0.56% of the company's stock is held by institutional investors, 83.12% is held by insiders, and 14.48% is held by retail investors.
What percentage of Inhibikase Therapeutics (IKT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.56% of Inhibikase Therapeutics (IKT) stock is held by institutional investors.
What percentage of Inhibikase Therapeutics (IKT) stock is held by retail investors?
According to the latest TipRanks data, approximately 14.48% of Inhibikase Therapeutics (IKT) stock is held by retail investors.
Who owns the most shares of Inhibikase Therapeutics (IKT)?
VANGUARD INDEX FUNDS owns the most shares of Inhibikase Therapeutics (IKT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.